Literature DB >> 816809

Formation of lipoprotein-X. Its relationship to bile compounds.

E Manzato, R Fellin, G Baggio, S Walch, W Neubeck, D Seidel.   

Abstract

In this study we have demonstrated that in native bile, lipids are organized in the form of a lipoprotein (bile LP) carrying albumin as apoprotein. The lipid composition of bile LP is almost identical to lipoprotein-X (LP-X, the characteristic lipoprotein of cholestasis). However, it differs from LP-X inits protein/lipid ratio and immunological and electrophoretic characteristics. Bile lipoprotein can be converted into "LP-X-like" material in vitro by adding albumin or serum to native bile. The LP-X-like material formed in vitro has physicochemical and chemical characteristics similar or identical to LP-X isolated from serum. As bile lipoprotein can be converted into LP-X-like material by the addition of albumin to bile, LP-X can be converted into bile-LP-like particles by adding bile salts to a LP-X-positive serum. Furthermore, experimental connection of the common bile duct to the vena cava is followed after a few hours by the appearance of LP-X-like material in the plasma. These facts taken together strongly suggest that bile LP is a precursor lipoprotein for LP-X and that it refluxes into the plasma pool under cholestatic conditions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816809      PMCID: PMC436778          DOI: 10.1172/JCI108393

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin:Cholesterol acyltransferase deficiency.

Authors:  Harald Torsvik; Kåre Berg; Harry N. Magnani; Walter J. McConathy; Peter Alaupovic; Egil Gjone
Journal:  FEBS Lett       Date:  1972-08-01       Impact factor: 4.124

2.  Diagnosis of extrahepatic biliary obstruction in infants by immunochemical detection of LP-X and modified 131 I-Rose Bengal excretion test.

Authors:  J R Poley; P Alaupovic; W J McConathy; D Seidel; C C Roy; A Weber
Journal:  J Lab Clin Med       Date:  1973-03

3.  Significance of the LP-X test in differential diagnosis of jaundice.

Authors:  D Seidel; H Gretz; C Ruppert
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

4.  Interaction by sonication of C-apolipoproteins with lipid: an electron microscopic study.

Authors:  T Forte; E Gong; A V Nichols
Journal:  Biochim Biophys Acta       Date:  1974-02-25

5.  Hypertriglyceridaemia secondary to liver disease.

Authors:  P Müller; R Felin; J Lambrecht; B Agostini; H Wieland; W Rost; D Seidel
Journal:  Eur J Clin Invest       Date:  1974-12-05       Impact factor: 4.686

6.  Macromolecular assemblies of lipid in bile.

Authors:  J I Howell; J A Lucy; R C Pirola; I A Bouchier
Journal:  Biochim Biophys Acta       Date:  1970-06-09

7.  Lipoprotein-X (LP-X) in liver disease.

Authors:  S Ritland; J P Blomhoff; K Elgjo; E Gjone
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

8.  Isolation and characterization of lipoprotein-X (LP-X) from canine.

Authors:  P Müller; U Fauser; R Fellin; H Wieland; D Seidel
Journal:  FEBS Lett       Date:  1973-12-15       Impact factor: 4.124

9.  Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice.

Authors:  D Seidel; B Agostini; P Müller
Journal:  Biochim Biophys Acta       Date:  1972-01-27

10.  [Fatty acid composition of phospholipids in abnormal serum lipoproteins of chlestasis].

Authors:  J Picard; D Veissiere; F Voyer; G Bereziat
Journal:  Clin Chim Acta       Date:  1972-01       Impact factor: 3.786

View more
  18 in total

1.  Severe hypercholesterolemia associated with decreased hepatic triglyceride lipase activity and pseudohyponatremia in patients after allogeneic stem cell transplantation.

Authors:  Yoshihiro Inamoto; Tamio Teramoto; Koji Shirai; Hideko Tsukamoto; Takaomi Sanda; Koichi Miyamura; Ikuo Yamamori; Noriyuki Hirabayashi; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

2.  Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Authors:  Calvin Yeang; Shucun Qin; Kailian Chen; David Q-H Wang; Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2010-06-11       Impact factor: 5.922

3.  [The significance of LP-X cholesterol in the differential diagnosis of cholestasis (author's transl)].

Authors:  H Wieland; H Meissner-Heins; C Heins; D Seidel
Journal:  Klin Wochenschr       Date:  1982-04-01

Review 4.  A review of new approaches to assessing hepatic function in animals.

Authors:  C E Cornelius
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

5.  Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile.

Authors:  R T Holzbach; A Kibe; E Thiel; J H Howell; M Marsh; R E Hermann
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

6.  [Studies on the structure and metabolism of lipoprotein-X (LP-X), the abnormal plasmalipoprotein in cholestasis (author's transl)].

Authors:  D Seidel
Journal:  Klin Wochenschr       Date:  1977-07-01

7.  Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse.

Authors:  R P Elferink; R Ottenhoff; J van Marle; C M Frijters; A J Smith; A K Groen
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

8.  Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects.

Authors:  G Baldo-Enzi; M R Baiocchi; M Grotto; A R Floreani; M Zagolin; M Chiaramonte; F Cera; R Fellin
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

9.  Secretion of lipoprotein-X by perfused livers of rats with cholestasis.

Authors:  T E Felker; R L Hamilton; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

10.  Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.

Authors:  A K Walli; D Seidel
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.